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Supplementary Figure 1: PKD isoforms expression and activation in a cellular model of neuronal 
excitotoxicity. (a) Cultures of primary cortical neurons were transduced with lentiviral particles for 
control shC, shPKD1, shPKD2 or both and analysed by immunoblotting with p-PKD (S916) (CST #2051) 
or total PKD (CST #2052) antibodies (see Supplementary Table 2). NSE was used as loading control. 
(b,c) RT-qPCR analysis of Prkd1, Prkd2 and Prkd3 gene expression in rat primary cortical neurons either 
(b) untreated or (c) stimulated with NMDA for various periods of time. Data are shown as mean+s.e.m 
(n=3 independent experiments) relative to (b) Prkd1 mRNA levels or (c) untreated cells (Crtl). (d) Dose-
dependency of PKD activation and inactivation by NMDA treatment. Representative immunoblot of PKD 
activity determined by analysing p-Ser916 signal in primary cortical neurons stimulated with different 
NMDA doses (10-50-100-150 !M) for 5 min (top panel) or 1 h (bottom panel). NSE was used as loading 
control. (n=3 independent experiments). (e) Effects of NMDA on neuronal survival. Primary cortical 
neurons were treated with excitotoxic concentrations of NMDA (50µM) for various periods of time and 
neuronal viability was measured by MTT assays. Data are expressed relative to untreated cultures as 
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mean+s.e.m (triplicates per condition, n=4 independent experiments) and analysed with two-tailed 
unpaired Student´s t-test. ***P <0.001. (f) Neurons were treated with ZVAD-fmk (25 µM) for 1h and 
then 4h with NMDA (50µM). Neuronal viability was measured by MTT assays. Data are shown relative 
to untreated neurons as mean+s.e.m (triplicates per condition, n=3 independent experiments). (g) 
Representative flow cytometry fluorescence histograms of ROS production in cultured neurons untreated 
(grey line) or treated with 50µM NMDA (black line) for 1 h (n=3 independent experiments). (h) Cortical 
neurons were incubated for 1 h with EGTA (2mM) and then treated with 50µM NMDA for 1 h. Lysates 
were analysed by immunoblotting (top panels) and PKD activity was determined by Ser916 auto-
phosphorylation. (Bottom panel) Quantification of p-Ser916 immunoblot signals relative to total PKD 
and the loading control NSE. Data are shown relative to control untreated cultures as mean+s.e.m (n=3 
independent experiments). (i) (Top panels) Representative immunoblot analysis of p-Ser916 PKD, total 
PKD, and NSE in neurons stimulated with Ca2+ ionophore (A23187; 4µM) for various periods of time. 
(Bottom panel) Quantification of p-Ser916 values was performed as in (h) (n=3 independent 
experiments). (j) Quantification of immunoblot signals of PKC-mediated activatory transphosphorylation 
of PKD Ser744/Ser748 relative to total PKD and the loading control NSE. Data are shown relative to 
untreated cultures (Crtl) as mean+s.e.m (n=3 independent experiments). (b-j) Data were analysed with 
two-tailed unpaired Student´s t-test. *P <0.05, **P <0.01, ***P <0.001. 
!
!
!
!
 
 
 
 
 
 
 
 
 
 
! 3!
!
!
 
Supplementary Figure 2: Characterization of a novel monoclonal antibody (mAb) specific for 
PKD1 phospho-tyrosine 93 (p-Tyr93). (a) Total lysates (100 µg) from primary cortical neurons treated 
for 1 h with the tyrosine phosphatase inhibitor pervanadate (PV; 1 mM) were analysed by 
immunoblotting for tyrosine phosphorylation.  The supernatant of a hybridoma clone specific for PKD1 
phosphorylated at Tyr93 (see Methods) was used for immunoblot detection of p-Tyr93 before (no 
peptide) or after neutralization with the immunizing phospho-peptide or its non-phosphorylated version 
(nonphospho-peptide). The same lysates were immunoblotted for PKD Tyr469 phosphorylation, total 
PKD and NSE. (b) Primary neurons were exposed for 3 h to the Src inhibitor SU6656 (5µM), and then 
treated with PV (1 mM) for 1 h. Lysates were analysed by immunoblotting with antibodies to the 
indicated proteins. (c) Cortical neurons were treated with PV (1 mM) for 1 h (top panel) or stimulated 
with H2O2 (1 mM) for 10 min (bottom panel). Total lysates and PKD p-Tyr93 immunoprecipitates were 
analysed by immunoblotting with anti p-Tyr93 and p-Ser916 antibodies. Short and long exposure images 
of PKD p-Tyr93 signal are included. Representative immunoblots are shown. 
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Supplementary Figure 3: Excitotoxic PKD early activation relies on PKC and Src family of kinases, 
whereas its dephosphorylation is independent of PP2A and PP2B and resembles that of p38. (a) 
Primary cortical neurons were incubated for 1 h with general inhibitors for PKC or Src family of kinases, 
GFI (3.5µM) or PP2 (5µM), respectively, and then treated with NMDA for 5 min. (b) Quantification of 
pSer916 immunoblot from lysates of cortical neurons incubated for 1 h with the PKC ! inhibitor Rottlerin 
(5 µM) or the Src inhibitor SU6656 (5µM), and then treated with NMDA for 5 min. The pSer916 signal 
was normalized to that of total PKD and NSE, and each value was represented relative to that of untreated 
cultures (Crtl). Quantification data are shown as mean+s.e.m (n=3 independent experiments) and 
analysed with two-tailed unpaired Student´s t-test. *P <0.05. (c-e) Cultures of primary cortical neurons 
were incubated for 1 h with NMDA in the absence or presence of (c) 1nM OA, as inhibitor of PP2A, or 
(d) 200ng/ml FK506 in combination with 100ng/ml cyclosporine A (CsA), to inhibit PP2B. Total lysates 
were analysed by immunoblotting with the indicated antibodies. NSE was used as protein loading control. 
(e) Phosphatases activation in an in vitro NMDA excitotoxicity model and their effects on different 
kinases.  Lysates from primary cortical cultures stimulated with NMDA for various periods of time were 
analysed by immunoblotting with the indicated antibodies. NSE was used as protein loading control. (a-e) 
Representative immunoblots of 3 independent experiments are shown.  
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Supplementary Figure 4: Neuronal PKD/NF-!B inactivation in mouse ischemic brain after short 
reperfusion times (a-c) Wild-type mice were sham-operated or subjected to 60 min of MCAO and 
sacrificed 5 h after reperfusion. (a) Representative T2W and ADC Magnetic Resonance Images (MRI) 
showing the edema in the ischemic hemisphere 5 h or 2 h after occlusion release, respectively. The 
pseudo-color scale indicates maximum and minimum ADC values in µm2/s. (b-c) Representative 
confocal microscopy images showing (b) p-Ser916 and (c) predominant nuclear localization of NF-"B 
staining in NeuN+ cells in brain from sham-operated animals, and the decrease in both signals on NeuN+ 
cells at the cortical penumbra area in ischemic brain. Zoom images from boxed regions are also shown. 
(Right panels) Percentage of NeuN+ cells containing p-Ser916 or nuclear NF-"B staining in the 
penumbra zone of MCAO-operated mice compared to the equivalent cortical region of sham-operated 
animals (n=100 neurons; n=3 sections per animal, n=3 animals per condition). Quantification data are 
shown as mean+s.e.m and analysed with two-tailed unpaired Student´s t-test. *P <0.05, **P <0.01. 
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Supplementary Figure 5: Pharmacological PKD inhibition blocks basal PKD activity and NMDA-
evoked PKD activation and potentiates neuronal death. (a-b) Representative PKD, p-PKD Ser916, 
and NSE immunoblot analysis from primary cortical neurons treated (a) for 1 h with the selective PKD 
inhibitor CRT0066101 (CRT) at different concentrations (0.5-10µM) or (b) with 10µM CRT for various 
periods of time before the stimulation with NMDA for 5 min (n=3 independent experiments). (c) 
Representative PKD, p-PKD Ser916, and NSE immunoblot analysis of primary cortical neurons 
incubated with 10µM CRT for 1 h before addition of NMDA for 5 min (left panel) and quantitative 
analysis of p-PKD Ser916 levels relative to those of total PKD and NSE expressed as fold increase over 
untreated cultures (right panel), (n=3 independent experiments). (d) Neuronal viability was measured by 
MTT assays in cortical neurons treated with NMDA for 2, 4 and 6 h, in the absence or presence of 
different doses of CRT (1, 2.5 and 5µM). Quantification data are expressed as mean+s.e.m (triplicates per 
condition; n=3 independent experiments) and analysed with two-tailed unpaired Student´s t-test. *P 
<0.05. 
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Supplementary Figure 6: Generation and characterization of CaMKII! neuronal PKD1 KO mice. 
(a) Schematic representation of the strategy used to generate mice with CaMKII!-conditional neuronal 
Prkd1 deletion. (b) Genomic DNA PCR assessing Cre, flox and recombination in brain cortex from 
PKD1 KO animals and PKD1floxed control littermates. (c) RT-PCR analysis of Prkd1, Prkd2 and Prkd3 
mRNA from PKD1floxed and PKD KO mice. (d) PKD immunoblot from cultured primary cortical neurons 
from PKD1floxed and PKD1 KO mice. (e-f) Two parallel and complete series of brain slices from 2 
months-old mice were stained with (e) Nissl or (f) NeuN (the area analysed by confocal microscopy is 
boxed in the upper brain coronal section scheme). Representative images are shown (n=3 animals per 
group). (g) Brain images of representative PKD1floxed and PKD1 KO mice after Evans blue intracardial 
perfusion (see Methods for details). Dorsal (upper row) and ventral (lower row) view showing the 
absence of vascular anatomical abnormalities in both genotypes. (Right panel) Quantification of the 
distance between the anastomotic line (dashed line in upper row, left) and the midline at 3 and 6 mm from 
the frontal pole of the brain shown as mean+s.e.m (4 PKD1floxed and 6 PKD1 KO animals per group). (h) 
PKD1floxed and PKD1 KO cultured primary neurons unstimulated or treated with NMDAR for 1 h were 
stained with the oxidative stress sensitive fluorescent dye DHE to detect ROS production. Representative 
confocal microscopy images are shown (n=4 independent experiments).  
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Supplementary Figure 7: I!B" accumulation and NF-!B inactivation in in vitro and in vivo models 
of excitotoxicity. (a) Representative immunoblots of levels and phosphorylation of IKK and I"B# from 
primary cortical neurons stimulated with 50µM NMDA for various periods of time (n=3 independent 
experiments). (b) (Left panel) Representative images of MAP2, phosphorylated active p-Ser536 at 
p65/NF-"B (p-NF-"B) and DAPI staining of primary cortical neurons treated with NMDA for 1 or 2 h. 
(Right panel) Percent of neurons bearing phosphorylated NF-"B nuclear staining before and after 
NMDARs overstimulation expressed relative to untreated cells (n=50-100 neurons per condition; n=3 
independent experiments). Quantification data are expressed as mean+s.e.m and analysed with two-tailed 
unpaired Student´s t-test. ***P <0.001. (c) Representative confocal images of NeuN, NF-"B and DAPI 
staining at the ischemic core in the brain striatum of sham- or MCAO-operated animals (n=3 sections per 
animal, n=3 animals per condition). See condensed nuclei in the ischemic zone. 
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Supplementary Figure 8: PKD1 overactivation does not substantially affect Calcium influx. (a) 
HEK293T cells were transfected with vectors for the expression of GFP, kinase-dead mutant PKD1 
(GFP-PKD1-KD), wild-type PKD1 (GFP-PKD1) or dephosphorylation resistant constitutively active 
mutant PKD1 (GFP-PKD1-Ca). Expressed GFP-fused proteins were immunoprecipitated with anti-GFP 
antibodies and subjected to an in vitro kinase assay followed by SDS-PAGE. After membrane transfer, 
autoradiography (top panel) and anti-GFP immunoblot (middle panel) of immunoprecipitates were 
obtained. Total lysates showed GFP levels of ectopically expressed proteins (bottom panel). (b) GFP or 
PKD1-Ca transduced neurons loaded with Fura red AM (5 µM) were visualized before or after NMDA 
stimulation. Representative images of GFP signal (left panel) and pseudocolor images representing 
fluorescence of Ca2+ are shown. The pseudo-color bar indicates minimum and maximum values of Fura 
Red ratio. Raw tracers of GFP (black line) or PKD1-Ca (red line) and quantification of mean maximum 
Ca2+ spike (right panel) to local application of NMDA (80 GFP and 80 PKD1-Ca neurons, n=3 
independent experiments). Quantification data are expressed as mean+s.e.m and analysed with two-tailed 
unpaired Student´s t-test.  
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Supplementary Figure 9: In vitro model of KA-induced neuronal death. (a) Neuronal viability was 
measured by MTT assays in primary cortical neurons treated with different doses of KA for several 
periods of time (2-48 h). (b) Primary cortical neurons were treated with the competitive AMPA/KA 
receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20µM) for 1 h prior to  KA 
stimulation (50µM) at different time points and neuronal viability was measured by MTT assays. (a,b) 
Data are shown as mean+s.e.m (triplicates per condition; n=3 independent experiments). (c) Neurons 
cultured on coverslips were incubated with CNQX (20µM) for 1 h prior to KA (50µM) treatment during 
24 h and co-stained for MAP2 and DAPI. Representative confocal microscope images of MAP2 and 
DAPI staining show CNQX neuroprotection from KA-induced damage (n=3 independent experiments).  
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Supplementary Figure 10: Whole Western blots for Figures 1b, 1c, 1d, and 1e. 
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Supplementary Figure 11: Whole Western blots for Figures 1f, 1g, and 1h. 
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Supplementary Figure 12: Whole Western blots for Figures 3c, 4a, 5b, 5f, and 6a, and for 
Supplementary Figures 1a and 1d. 
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Supplementary Figure 13: Whole Western blots for Supplementary Figure 1h, Supplementary Figure 1i, 
Supplementary Figure 2a, and Supplementary Figure 2b. 
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Supplementary Figure 14: Whole Western blots for Supplementary Figure 2c, Supplementary Figure 
3a, Supplementary Figure 3c, Supplementary Figure 3d, and Supplementary Figure 3e. 
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Supplementary Figure 15: Whole Western blots for Supplementary Figure 5a, Supplementary Figure 
5b, Supplementary Figure 5c, Supplementary Figure 6d, and Supplementary Figure 7a, and for 
autoradiography and Western blots for Supplementary Figure 8a. 
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Supplementary Table 1. Details of the post-mortem cortex brain samples from 
human control individuals and stroke patients. Age (years), gender and post-mortem 
interval (hours) (PMI), of control subjects (C) and stroke patients (S). Post-stroke 
survival period and existence of recurrent strokes are also indicated.  
Sample ID Age Gender PMI 
Post-stroke  
survival period 
Recurrent strokes 
C-1 70 M 2  _ 
C-2 73 M 15  _ 
C-3 64 M 19  _ 
S-1 74 M - 7 days None 
S-2 61 M 6 > 7 days 2nd episode < 24h 
S-3 89 M 3 > 7 days None 
S-4 88 F 5 > 7 days None 
 
 
 
 
 
 
 
 
 
 
 
 
! 19!
Supplementary Table 2. Details of the antibodies used. 
Antibody Supplier Catalog number Dilution 
PKD Cell Signaling 2052 WB 1:1000 
phospho-PKD-S916 Cell Signaling 2051 WB 1:250 
IMF 1:250*-1:50** 
phospho-PKD-S744/748 Cell Signaling 2054 WB 1:200 
phospho-PKD-Y463 Abcam ab59415 WB 1:500 
phospho-PKD1-Y93, 
clone 6E8 
T. Iglesias - WB Undiluited 
supernatant 
p38 Cell Signaling 9212 WB 1:500 
phospho-p38-T180/Y182 Cell Signaling 9211 WB 1:500 
IKK$ (L570) Cell Signaling 2678 WB 1:500 
phospho-S176/177 
IKK#/$ 
Biorbyt orb127876 WB 1:500 
DAPK Sigma-Aldrich D2178 WB 1:1000 
phospho-S308 DAPK Sigma-Aldrich D4941 WB 1:1000 
Superoxide dismutase 2 
(SOD2) 
Abcam ab13533 WB 1:1000 
Microtubule associated 
protein 2 (MAP2) 
Abcam ab5392 IMF 1:10000 
NF-kB p65 (C-20) Santa Cruz sc-372 IMF 1:250*-1:50** 
Phospho-NF-kB p65 –
S536 
Cell Signaling 3031 IMF 1:500 
IkB# (C-21) Santa Cruz sc-371 WB 1:500 
DUSP1 Santa Cruz sc-370 WB 1:500 
NSE Millipore AB951 WB 1:10000 
NeuN, clone A60 Millipore MAB377 IMF 1:1000*-
1:100** 
Spectrin Millipore MAB1622 WB 1:2000 
STEP Novus Biologicals NB300-202SS WB 1:1000 
MDA Jaica 1F83 IMF 1:250 
GFP Thermo Fisher 
Scientific 
Invitrogen 
A6455 WB 1:1000 
IMF 1:1000 
*Cultured neurons and animal brain samples  **Human brain samples 
